David M Ferguson

11PUBLICATIONS
20CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Computational chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 15, 2026
Toll-Like Receptor 7/8 Antagonist Promotes Interleukin-10-Mediated Anti-inflammatory Therapy.

Grahmm A Funk, Jin Xie, Tamara A Kucaba

|Nov 13, 2025
Enhancing Cancer Therapy with TLR7/8 Agonists: Applications in Vaccines and Combination Treatments.

Jagannath Mondal, Swayam Prabha, Thomas S Griffith

|Jul 10, 2023
Proteasomal Stimulation by MK886 and Its Derivatives Can Rescue Tau-Induced Neurite Pathology.

Elly E Liao, Mu Yang, Noah Nathan Kochen

|Jun 26, 2023
Zafirlukast Is a Promising Scaffold for Selectively Inhibiting TNFR1 Signaling.

Nagamani Vunnam, Mu Yang, Chih Hung Lo

|Dec 23, 2022
Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy.

Shubhmita Bhatnagar, Vishnu Revuri, Manan Shah

|May 14, 2022
Parameterization and Application of the General Amber Force Field to Model Fluoro Substituted Furanose Moieties and Nucleosides.

Diego E Escalante, Courtney C Aldrich, David M Ferguson

Pageof 2